U.S. flag

An official website of the United States government

NM_000155.4(GALT):c.265T>G (p.Tyr89Asp) AND not provided

Germline classification:
Pathogenic/Likely pathogenic (3 submissions)
Last evaluated:
Dec 6, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000482282.13

Allele description [Variation Report for NM_000155.4(GALT):c.265T>G (p.Tyr89Asp)]

NM_000155.4(GALT):c.265T>G (p.Tyr89Asp)

Gene:
GALT:galactose-1-phosphate uridylyltransferase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
9p13.3
Genomic location:
Preferred name:
NM_000155.4(GALT):c.265T>G (p.Tyr89Asp)
Other names:
p.Tyr89Asp
HGVS:
  • NC_000009.12:g.34647504T>G
  • NG_009029.2:g.5916T>G
  • NG_028966.1:g.320T>G
  • NM_000155.3:c.265T>G
  • NM_000155.4:c.265T>GMANE SELECT
  • NM_001258332.2:c.50+246T>G
  • NP_000146.2:p.Tyr89Asp
  • NC_000009.11:g.34647501T>G
  • NM_000155.2:c.265T>G
  • NM_000155.4:c.265T>G
Links:
dbSNP: rs111033666
NCBI 1000 Genomes Browser:
rs111033666
Molecular consequence:
  • NM_001258332.2:c.50+246T>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000155.4:c.265T>G - missense variant - [Sequence Ontology: SO:0001583]
Observations:
6

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000567775GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Pathogenic
(Aug 26, 2015)
germlineclinical testing

Citation Link,

SCV000854788Eurofins Ntd Llc (ga)
criteria provided, single submitter

(EGL Classification Definitions 2015)
Pathogenic
(Nov 28, 2017)
germlineclinical testing

Citation Link,

SCV004226583Mayo Clinic Laboratories, Mayo Clinic
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Dec 6, 2022)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknown6not providednot providednot providednot providedclinical testing

Citations

PubMed

Molecular basis of classic galactosemia from the structure of human galactose 1-phosphate uridylyltransferase.

McCorvie TJ, Kopec J, Pey AL, Fitzpatrick F, Patel D, Chalk R, Shrestha L, Yue WW.

Hum Mol Genet. 2016 Jun 1;25(11):2234-2244. Epub 2016 Mar 22.

PubMed [citation]
PMID:
27005423
PMCID:
PMC5081055

MotSASi: Functional short linear motifs (SLiMs) prediction based on genomic single nucleotide variants and structural data.

Martín M, Brunello FG, Modenutti CP, Nicola JP, Marti MA.

Biochimie. 2022 Jun;197:59-73. doi: 10.1016/j.biochi.2022.02.002. Epub 2022 Feb 5.

PubMed [citation]
PMID:
35134457
See all PubMed Citations (4)

Details of each submission

From GeneDx, SCV000567775.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The Y89D variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in nearby residues (Y89H, N86D and F95L) have been reported in the Human Gene Mutation Database in association with galactosemia (Stenson et al., 2014), supporting the functional importance of this region of the protein. Therefore, we interpret Y89D to be a pathogenic variant.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Eurofins Ntd Llc (ga), SCV000854788.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided4not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided4not providednot providednot provided

From Mayo Clinic Laboratories, Mayo Clinic, SCV004226583.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided2not providednot providedclinical testing PubMed (4)

Description

PP3, PP4, PM2, PS4_moderate

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided2not providednot providednot provided

Last Updated: Sep 8, 2024